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ABSTRACT 
A novel synthesis of N-fused imino-1,2,4-thiadiazolo derivatives is 
described. This approach involves the inexpensive, nontoxic, recover-
able, and easy to handle montmorillonite K10 that catalyzes the 
coupling of 3-aminoisoquinolines and phenylisothiocyanates to afford 
the N-fused imino-1,2,4-thiadiazolo isoquinoline motifs in exemplary 
yields. The main attractions of this synthetic strategy were simple 
procedure and excellent yields.  
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Introduction 
1,2,4-Thiadiazoles are privileged five-membered heterocyclic motifs which serve as useful 
building blocks in many agrochemical, industrial, pharmaceutical, and biological agents.[1,2] 
Multitude of compounds bearing this nucleus have entered preclinical and clinical trials 
for over a long period. 1,2,4-Thiadiazoles are prevalent in many pharmaceutically relevant 
compounds (Fig. 1), such as dendrodoine (1) (an antioxidant),[3] cefozopran (2) (an 
antibiotic),[4] penicilliumthiamine B (3) (an anticancer)[5], and α(Z)-[3-(3,5-di-tert-butyl-4- 
hydroxyphenyl)-1,2,4-thiadiazol-5-yl]-N-tert-butylnitrone (4) (a neuroprotective drug).[6] 
Consequently, the compounds belonging to this class have received remarkable attention 
on the development of potential drugs with interesting biological activities, such as 
anticancer,[7] antiulcerative,[8] antidiabetic,[9] antimicrobial,[10] antibacterial,[11] and 
antirheumatic[12] agents as well as they possess significant muscarinic[13] and cardioprotec-
tive activities.[14] In addition, 1,2,4-thiadiazoles can also be applied in dyes, lubricant addi-
tives, and vulcanization accelerators.[15] Despite the significance of these skeletons, only 
few strategies for the synthesis of 1,2,4-thiadiazole derivatives have been reported[16–18], 
which involves (i) oxidative cyclization of N-thioacyl amidine, (ii) cycloaddition of nitrile 
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sulfides with a nitrile, (iii) oxidation of thioamides or thioureas, (iv) condensation of 
amidines with halogenated methylmercaptans, (v) from imidoyl and guanyl thioureas, (vi) 
by oxidative dimerization of thiocarboxamides, and (vii) from amidines, elemental sulfur, 
and 2-methylquinolines or aldehydes. Recently, a protocol was reported by Nakka et al. that 
involves the oxidative cyclization of 2-aminopyridine/amidine and isothiocyanate using mol-
ecular iodine. Yet, there are still disadvantages associated with this methodology, such as high 
loading of expensive molecular iodine catalyst,[19] product diversity, lack of convergence, and 
low yields. For this reason, the development of efficient and simple methodology for the syn-
thesis of 1,2,4-thiadiazole derivatives still remains a highly demanding goal in organic 
synthesis. 
Recently, environmentally benign and noncorrosive clays as solid acid catalysts have 
emerged as inexpensive, nontoxic, and efficient oxidizing agents. They often allow very 
simple isolation procedures.[20] As a catalyst, montmorillonite K10 clay has been 
extensively used in innumerable organic transformations, such as Friedlander synthesis, 
Heck vinylation, Hosomi–Sakurai reaction, Knoevenagel reaction, Markovnikov addition, 
Pechmann condensation, Beckmann rearrangement, pinacol–pinacolone rearrangement[21], 
and[1,3] shift reactions.[22] Furthermore, it can mediate addition, condensation, esterification, 
oxidation, and isomerization reactions.[23] Montmorillonite K10 clay is an efficient 
heterogeneous catalyst for the one-pot multicomponent reactions[24] as well as domino 
reactions.[25] Over and above it is very fascinating to note that montmorillonite K10 could 
surrogate for transition metal as a catalyst.[26] 
However, to the best of our knowledge, there seems to be no reports in the literature 
on montmorillonite K10-catalyzed N−S bond formation reactions for the synthesis of 
Figure 1. Some biologically active 1,2,4-thiadiazole derivatives.  
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1,2,4-thiadiazoles. As part of our continued interest on the development of efficient 
synthetic methods,[27–35] here we wish to report for the first time the establishment of 
N−S bond by involving montmorillonite K10 as a catalyst for the rapid construction of 
biologically significant N-fused imino 1,2,4-thiadiazolo isoquinoline scaffolds. 
Results and discussion 
To investigate the optimizing reaction conditions for the synthesis of N-fused iminothia-
diazolo isoquinoline derivatives, we performed the two-component reaction between 
3-aminoisoquinoline (1a) and phenylisothiocyanate (2a) in DMF at room temperature 
for 24 h as a model (Table 1, entry 1). The product (3a) was not obtained and it indicates 
that a catalyst should absolutely be required for this reaction. The reaction was investigated 
in different catalysts with a view to finding the optimal conditions to maximize the yield of 
the product. Various catalysts such as ceric ammonium sulfate, ZnCl2, SnCl2, BiCl3, ceric 
ammonium nitrate, zeolite HY, and montmorillonite KSF (Table 1, entries 2–8) afforded a 
lower yield of (3a). When the same reaction was performed in the presence of 3 mol% of 
montmorillonite K10, the yield was 53% (Table 1, entry 9). 
Next the reaction was performed in various solvents as well as under solvent-free con-
ditions. Acetonitrile (Table 1, entry 14) was proved to be superior to 1,4-dioxane, DMSO, 
Table 1. Optimization studies for the synthesis of (3a)a. 
Entry Catalyst 
Amount of  
catalyst (mol%) Solvent Time (h) Temp (°C) Yield (%)   
1 No catalyst – DMF 24 25 –  
2 Ceric ammonium sulphate 10 DMF 8 25 24  
3 ZnCl2 10 DMF 8 25 5  
4 SnCl2 10 DMF 8 25 10  
5 BiCl3 10 DMF 8 25 14  
6 Ceric ammonium nitrate 10 DMF 8 25 29  
7 Zeolite HY 10 DMF 8 25 9  
8 Montmorillonite KSF 10 DMF 8 25 32  
9 Montmorillonite K10 3 DMF 8 25 53 
10 Montmorillonite K10 3 No solvent 8 25 6 
11 Montmorillonite K10 3 1,4-Dioxane 8 25 50 
12 Montmorillonite K10 3 DMSO 8 25 60 
13 Montmorillonite K10 3 Toluene 5 25 63 
14 Montmorillonite K10 3 CH3CN 5 25 75 
15 Montmorillonite K10 5 CH3CN 5 25 80 
16 Montmorillonite K10 10 CH3CN 2 25 93 
17 Montmorillonite K10 20 CH3CN 2 25 93 
18 Montmorillonite K10 30 CH3CN 2 25 89 
19 Montmorillonite K10 10 CH3CN 2 60 49 
20 Montmorillonite K10 10 CH3CN 2 Reflux 35 
aReaction conditions: 1a (3.4 mmol, 1 equiv.), 2a (3.4 mmol, 1 equiv.), catalyst (x mol%), and solvent (2 mL).   
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toluene, and solvent-free conditions as the use of these solvents provided the model in 
lower yield. Increasing the mol% of montmorillonite K10 from 3 to 10 increased the yield 
(Table 1, entry 16). Further increase (Table 1, entries 17 and 18) has no effect in the yield of 
(3a). Screening of temperature (Table 1, entries 19 and 20) gave no obvious improvement 
in the yield of (3a). When taking the molar ratio at 1:1 of 1a/2a, catalyzed by montmor-
illonite K10 in acetonitrile at room temperature, the target product (3a) could be obtained 
in 93% yield. 
Under the optimum conditions (Table 1, entry 16), the scope of this promising 
reaction was explored by varying the structure of 3-aminoisoquinoline and phenyli-
sothiocyanate. The reaction proceeds smoothly under mild reaction conditions at room 
temperature. This synthetic protocol allows us to introduce great molecular diversity. A 
collection of isothiocyanates with various substituents was investigated. Phenyl 
isothiocyanate (2a) produced the target compound (3a) in 93% yield. Arylisothiocya-
nates with electron-withdrawing groups like nitro and chloro (Table 2, entries 5 and 
6) were well tolerated under this reaction condition, and the target molecules (3e and 
3f) were furnished in 87 and 89% yields, respectively. The arylisothiocyanates holding 
electron-donating groups such as methoxy, methyl, and isopropyl groups (Table 2, 
entries 2–4) also exhibited tolerance and provided the desired products in 
excellent yields (3b−d). In addition, switching to an alicyclic isothiocyanate such as 
cyclopropyl isothiocyanate (Table 2, entry 7) was also afforded well, and the product 
(3g) was isolated with 82% yield. Aliphatic isothiocyanates having ethyl and tertiary 
butyl chains (Table 2, entries 8 and 9) also encountered this transformation to give 
the corresponding products in exemplary yields (3h−i). It is noteworthy that steric 
hindrance (3b and 3g) and electronic factors of substituents on phenyl isothiocyanates 
(Table 2, entries 2 and 7) apparently performed an insignificant effect on the yield of 
products. 
To further examine the scope and limitations of the reaction, we surveyed various 3- 
aminoisoquinolines (1b and 1c) with a variety of isothiocyanates. 3-Aminoisoquinoline 
having electron-donating methoxy group (Table 2, entries 10–17) tolerated the reaction 
and did not bear any significant effect on the reaction yield (3j−q). Electron-withdraw-
ing group such as nitro group (Table 2, entries 18–23) was compatible and produced 
very indicative results for the corresponding products (3r–w). 
The reusability of montmorillonite K10 catalyst was studied for the reaction 
between 3-aminoisoquinoline (1a) and phenylisothiocyanate (2a) under the estab-
lished reaction condition. The reaction time was maintained constant in each cycle 
(2 h), and the results are recorded in Table 3. When the recycled montmorillonite 
K10 was used in this reaction, it was noted that the reaction occurred smoothly 
and the corresponding product (3a) was obtained in 91% yield. The catalyst was 
recovered after each cycle, activated, and reused in the next cycle. The results showed 
that the catalyst can be reused for four consecutive cycles without any obvious drop in 
its activity. 
Based on the present results, a plausible mechanism (Scheme 1) for this reaction is pro-
posed. Initially, an intermediate is formed by the nucleophilic attack of activated 3-aminoi-
soquinoline on isothiocyanate. Finally, the intramolecular nucleophilic attack of the NH 
group on the sulfur atom followed by dehydrogenation furnished the N-fused imino- 
1,2,4-thiadiazolo isoquinoline derivatives. 
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Table 2. Synthesis of N-fused imino-1,2,4-thiadiazolo isoquinoline (3a–w)a. 




(%)   
1 H 2 93  
2 H 1 96  
3 H 1 92  
4 H 2 91   
(Continued) 
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Table 2. Continued. 





5 H 3 87  
6 H 3 89  
7 H 2 82  
8 H 3 83  
9 H 2 82   
(Continued) 
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Table 2. Continued. 





10 6-OMe 1 94 
11 6-OMe 1 95 
12 6-OMe 2 92 
13 6-OMe 3 89   
(Continued) 
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Table 2. Continued. 





14 6-OMe 2 88 
15 6-OMe 3 84 
16 6-OMe 2 85 
17 6-OMe 1 86 
18 7-NO2 2 90   
(Continued) 
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Table 2. Continued. 





19 7-NO2 1 91 
20 7-NO2 3 83 
21 7-NO2 3 84 
22 7-NO2 2 89 
23 7-NO2 3 91 
aReaction conditions: 1a–c (3.4 mmol, 1 equiv.), 2a–i (3.4 mmol, 1 equiv.), montmorillonite K10 (10 mol%), and acetonitrile 
(2 mL) at rt for 1 − 3 h.   
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Conclusion 
In summary, the present work described a novel and facile oxidative protocol for N−S bond 
formation towards the synthesis of N-fused imino-1,2,4-thiadiazolo isoquinoline deriva-
tives from 3-aminoisoquinolines and isothiocyanates through montmorillonite K10. This 
protocol features a broad substrate scope with economical, environmentally benign, and 
nontoxic montmorillonite K10 as the catalyst, with no employment of any ligand, metal, 
base, or additive and proceeded with an easy workup procedure. 
Experimental section 
General information 
Unless otherwise noted, common reagents and substrates were obtained from commercial 
suppliers and used without further purification. Molecules 1b[36] and 1c[37] were prepared 
from the earlier literature methods. Melting points were recorded on a melting point 
apparatus and they are reported as uncorrected. All reactions were monitored by TLC with 
GF254 silica gel precoated plates. Infrared spectra were measured on an Agilent Cary 630 
FT-IR spectrophotometer. 1H NMR (400 MHz) spectra were obtained on a Bruker WH- 
200 spectrometer and 13C NMR (100 MHz) on Agilent VNRMS spectrometer with CDCl3 
as solvent and TMS as an internal standard [(s ¼ singlet, d ¼ doublet, t ¼ triplet, 
Table 3. Reusability of montmorillonite K10 catalyst for the synthesis of (3a)a. 
Run Time (h) Yield (%)  
1 2 93 
2 2 91 
3 2 90 
4 2 88 
5 2 86 
aReaction conditions: 1a (3.4 mmol, 1 equiv.), 2a (3.4 mmol, 1 equiv.), montmorillonite K10 (10 mol%) and acetonitrile (2 mL) 
at rt for 2 h.   
Scheme 1. Plausible mechanism for the synthesis of N-fused imino-1,2,4-thiadiazolo isoquinoline 
derivatives.  
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q ¼ quartet, m ¼multiplet), coupling constant (Hz)]. Chemical shifts are reported in 
δ units, parts per million (ppm) relative to the residual chloroform (1H 7.26 ppm and 
13C 77.16 ppm) in the deuterated solvent. Mass spectra were recorded on an Agilent 
LC–MS/high-resolution magnetic sector mass spectrometer. Elemental analysis was 
performed on an Elemental Vario Micro Cube rapid analyzer. 
Typical experimental procedure for the synthesis of N-fused  
imino-1,2,4-thiadiazolo isoquinoline (3a) 
A round-bottom flask containing commercially available montmorillonite K10 (10 mol%) was 
placed in an oven at 120–130 °C for 30 min and then it was cooled to room temperature under 
nitrogen protection. To the activated montmorillonite K10 was added, phenyl isothiocyanate 
(0.468 g, 3.4 mmol) and 3-aminoisoquinoline (0.5 g, 3.4 mmol) followed by acetonitrile 
(2 mL) at room temperature. The resulting suspension was stirred at room temperature for 
2 h. When the reaction was completed (detected by TLC), ethyl acetate (30 mL) was added 
and the catalyst was filtered off to recover. The organic layer was washed with water 
(3 � 30 mL), and finally with half saturated brine, dried over anhydrous Na2SO4 and concen-
trated by rotary evaporator. Finally, the residue was purified by recrystallization from ethanol. 
N-(3H-[1,2,4]thiadiazolo[4,3-b]isoquinolin-3-ylidene)aniline (3a) 
Yield 93% (877 mg); yellow solid; mp: 120–122 °C; IR (ATR, cm−1): 1664 (C=N), 1648 
(C=N); 1H NMR (CDCl3, 400 MHz) δ: 6.29 (d, 2H, J ¼ 10 Hz), 6.56 (s, 2H), 7.00 (d, 2H, 
J ¼ 9.6 Hz), 7.31 (t, 1H, J ¼ 6.8 Hz), 7.42 (t, 2H, J ¼ 7.6 Hz), 7.89 (t, 2H, J ¼ 7.2 Hz) 
ppm; 13C NMR (CDCl3, 100 MHz) δ: 110.2, 118.0 (2C), 121.4, 122.5 (2C), 122.9, 126.0 
(2C), 127.3, 130.2 (2C), 144.1, 149.0, 152.5, 158.2 ppm; LCMS m/z: [MþH]þ Calcd for 
C16H12N3S 278.35; found 278.4; Anal. Calcd for C16H11N3S: C, 69.29; H, 4.00; N, 15.15. 
Found: C, 69.19; H, 3.93; N, 15.09. 
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